TRIM21 and systemic lupus erythematosus: As a result, only 10 out of 317 SLE patients showed QTc prolongation, a sample size that is underpowered for any statistical comparison between anti-Ro/SSA-positive (4/111, 3.6%) and -negative subjects (83).